Document ID: chunk:federal_register_of_legislation:F2019L00229:clause:1_1
Version: federal_register_of_legislation:F2019L00229
Segment Type: clause
Provision Reference: sch 1 cl 1
Character Range: 7537–10950

1               Definitions
In this instrument:
                                      DSM-5 means the American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition.  Arlington, VA, American Psychiatric Association, 2013.
                                     major neurocognitive disorder means:
         (a)          evidence of significant cognitive decline from a previous level of performance in one or more cognitive domains (complex attention, executive function, learning and memory, language, perceptual-motor, or social cognition) based on:
            (i)            concern of the individual, a knowledgeable informant, or the clinician that there has been a significant decline in cognitive function; and
            (ii)         a substantial impairment in cognitive performance, documented by standardised neuropsychological testing or another qualified clinical assessment; and
         (b)          the cognitive deficits interfere with independence in everyday activities (that is, at a minimum, requiring assistance with complex instrumental activities of daily living such as paying bills or managing medications).
                                      mild neurocognitive disorder means evidence of modest cognitive decline from a previous level of performance in one or more cognitive domains (complex attention, executive function, learning and memory, language, perceptual-motor, or social cognition) based on:
         (a)          concern of the individual, a knowledgeable informant, or the clinician that there has been a mild decline in cognitive function; and
         (b)          a modest impairment in cognitive performance, documented by standardised neuropsychological testing.
                                     MRCA means the Military Rehabilitation and Compensation Act 2004.
                                     neurocognitive disorder with Lewy bodies—see subsection 7(2).
                                     relevant service means:
         (a)          operational service under the VEA;
         (b)          peacekeeping service under the VEA;
         (c)          hazardous service under the VEA;
         (d)          British nuclear test defence service under the VEA;
         (e)          warlike service under the MRCA; or
         (f)           non-warlike service under the MRCA.
Note: MRCA and VEA are also defined in the Schedule 1 - Dictionary.
                                     specified list of anticholinergic drugs means:
         (a)          antidepressants (amitriptyline, amoxapine, clomipramine, desipramine, doxepin, imipramine, nortriptyline, paroxetine, protriptyline and trimipramine);
         (b)          antiparkinson agents (benztropine, biperiden, chlorphenoxamine, cycrimine, ethopropazine, procyclidine and trihexyphenidyl); or
         (c)          bladder antimuscarinics (darifenacin, fesoterodine, flavoxate, oxybutynin, solifenacin, tolterodine and trospium).
                                     terminal event means the proximate or ultimate cause of death and includes the following:
         (a)           pneumonia;
         (b)           respiratory failure;
         (c)           cardiac arrest;
         (d)           circulatory failure; or
         (e)           cessation of brain function.
                                     VEA means the Veterans' Entitlements Act 1986.